日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

全球 15 家实验室开展 SARS-CoV-2 抗原性合作比较

Polina Brangel, Sina Tureli, Barbara Mühlemann, Nicole Liechti, Daniel Zysset, Olivier Engler, Isabel Hunger-Glaser, Ioana Ghiga, Giada Mattiuzzo, Isabella Eckerle, Meriem Bekliz, Annika Rössler, Melanie M Schmitt, Ludwig Knabl, Janine Kimpel, Luis Fernando Lopez Tort, Mia Ferreira de Araujo, Any Ca

GB Virus B and Hepatitis C Virus, Distantly Related Hepaciviruses, Share an Entry Factor, Claudin-1

GB 病毒 B 和丙型肝炎病毒,远亲丙型肝炎病毒,共享一个进入因子 Claudin-1

Kamilla Toon, Mphatso D Kalemera, Machaela Palor, Nicola J Rose, Yasuhiro Takeuchi, Joe Grove, Giada Mattiuzzo

Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses

通过对早期患者反应的深度挖掘,发现交叉反应性 SARS-CoV-2 中和抗体

Georgia Bullen, Jacob D Galson, Gareth Hall, Pedro Villar, Lien Moreels, Line Ledsgaard, Giada Mattiuzzo, Emma M Bentley, Edward W Masters, David Tang, Sophie Millett, Danielle Tongue, Richard Brown, Ioannis Diamantopoulos, Kothai Parthiban, Claire Tebbutt, Rachael Leah, Krishna Chaitanya, Sandra Er

A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency

四聚体 ACE2 蛋白可广泛中和令人担忧的 SARS-CoV-2 刺突蛋白变体,且效力增强

Adam Leach, F Tudor Ilca, Zulaikha Akbar, Mathieu Ferrari, Emma M Bentley, Giada Mattiuzzo, Shimobi Onuoha, Ami Miller, Hanif Ali, Terence H Rabbitts

Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants

一种新型ACE2靶向疗法的特性分析:该疗法对SARS-CoV-2变异株的活性增强而非降低

Mathieu Ferrari ,Leila Mekkaoui ,F Tudor Ilca ,Zulaikha Akbar ,Reyisa Bughda ,Katarina Lamb ,Katarzyna Ward ,Farhaan Parekh ,Rajeev Karattil ,Christopher Allen ,Philip Wu ,Vania Baldan ,Giada Mattiuzzo ,Emma M Bentley ,Yasuhiro Takeuchi ,James Sillibourne ,Preeta Datta ,Alexander Kinna ,Martin Pule ,Shimobi C Onuoha

A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection

超强四聚化 ACE2 蛋白表现出增强的 SARS-CoV-2 病毒感染中和作用

Ami Miller, Adam Leach, Jemima Thomas, Craig McAndrew, Emma Bentley, Giada Mattiuzzo, Lijo John, Ali Mirazimi, Gemma Harris, Nadisha Gamage, Stephen Carr, Hanif Ali, Rob Van Montfort, Terence Rabbitts

Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins

实施一种设计多价性的方法,以显著增强临床试验抗 SARS-CoV-2 抗体与野生型刺突蛋白和关注变体蛋白的结合

Adam Leach #, Ami Miller #, Emma Bentley, Giada Mattiuzzo, Jemima Thomas, Craig McAndrew, Rob Van Montfort, Terence Rabbitts

Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes

严重急性呼吸道综合征冠状病毒 2 (SARS-CoV-2) 慢病毒假型的生产、滴定、中和、储存和冻干

Cecilia Di Genova, Alex Sampson, Simon Scott, Diego Cantoni, Martin Mayora-Neto, Emma Bentley, Giada Mattiuzzo, Edward Wright, Mariliza Derveni, Bethany Auld, Bill T Ferrara, Dale Harrison, Mohamed Said, Arwa Selim, Elinor Thompson, Craig Thompson, George Carnell, Nigel Temperton

Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike

SARS-CoV-2 刺突蛋白假型慢病毒载体的生产和滴定的优化方法

Leila Mekkaoui, Emma M Bentley, Mathieu Ferrari, Katarina Lamb, Katarzyna Ward, Rajeev Karattil, Zulaikha Akbar, Reyisa Bughda, James Sillibourne, Shimobi Onuoha, Giada Mattiuzzo, Yasuhiro Takeuchi, Martin Pule

A bipartite structural organization defines the SERINC family of HIV-1 restriction factors

HIV-1 限制因子 SERINC 家族由二分结构组成

Valerie E Pye, Annachiara Rosa #, Cinzia Bertelli #, Weston B Struwe, Sarah L Maslen, Robin Corey, Idlir Liko, Mark Hassall, Giada Mattiuzzo, Allison Ballandras-Colas, Andrea Nans, Yasuhiro Takeuchi, Phillip J Stansfeld, J Mark Skehel, Carol V Robinson, Massimo Pizzato, Peter Cherepanov